3 min. read
We have summarized our recent presentation, Identifying Potential Acute Health Hazards from Exposures to (S)-6-Methylnicotine to Inform Product Development, from the Tobacco Science Research Conference. This overview covers key findings and insights contributing to ongoing research in the field. Read More
1 min. read
We are proud to announce that McKinney RSA is now officially certified as a small, minority-owned business (SMBE) through the […] Read More
2 min. read
We recently had the pleasure of participating in the Cannabis Science Conference 2024, a premier event that brought together industry leaders, scientists, and regulatory experts to share their insights and advancements in the field. Our social media coverage highlighted several key moments from the conference, showcasing the breadth of knowledge and innovation present. Read More
2 min. read
The CannMed24 conference, held from May 12-15, was a valuable event for professionals in the cannabis and biopharma industries. This year’s gathering highlighted the burgeoning partnership between biopharma companies and the cannabis sector, driven by both anecdotal evidence of cannabis' benefits and an increasing demand for scientifically rigorous research and development. Read More
2 min. read
Non-Targeted Chemical Analysis: Nontargeted chemical analysis is a powerful technique to simplify and understand the vastness of molecular complexity that […] Read More
6 min. read
We gave a presentation on the latest regulatory frameworks for cannabis products at the Keller and Heckman Symposium. This is […] Read More
2 min. read
Exclusive Insights from Cheryl K. Olson Sc.D. Where are we with ESG? Environmental, social and governance issues, that is. In […] Read More
4 min. read
By majority (10-6) opinion the United States Court of Appeal for the Fifth Circuit has determined that the Premarket Tobacco […] Read More
1 min. read
Understanding the Transformation: Unpacking International Tobacco Legislation, Upcoming TPD Changes, FDA CTP’s Role, and the Evolving Global Regulatory Scenario Read More
"*" indicates required fields